Founded in 2014 in San Diego, Capella Therapeutics is focused on the discovery and development of small molecule drugs to treat cancer and inflammatory diseases. Capella Therapeutics was founded by Yun Long, Ph.D., a successful medicinal chemist with biotech experiences at Ligand, Galapagos/Biofocus, Nitto Denko Technology, GNF, Vertex, and Well Spring Biosciences. Dr. Long encouraged Alan Lewis, Ph.D., David Anderson, Ph.D. and Tony Hunter Ph.D. to join him to further develop the company. Members of this team have successfully developed numerous oncology and anti-inflammatory drugs from concept to market. They all previously worked closely together at Signal Pharmaceuticals and the Signal Division of Celgene.
View Top Employees from Capella Therapeutics Inc| Website | http://www.capellatherapeutics.com |
| Revenue | $5 million |
| Employees | View employees |
| Founded | 2014 |
| Address | 7909 Silverton Ave, Ste 209, San Diego, California 92126, US |
| Industry | Business Services General, Biotechnology, Business Services, Science and Engineering, Health Care |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies |
Looking for a particular Capella Therapeutics Inc employee's phone or email?
Capella Therapeutics Inc Questions
The Capella Therapeutics Inc annual revenue was $5 million in 2024.
Capella Therapeutics Inc is based in San Diego, California.
The NAICS codes for Capella Therapeutics Inc are [5417, 541, 541714, 54, 54171].
The SIC codes for Capella Therapeutics Inc are [87, 873].
